Indeed, a poor prognosis of osteosarcoma patients expressing IGF-I was determined by implementing tissue microarray analysis [31], and a generalized IGF-IR signaling input in sarcoma progression was demonstrated by meta-analysis correlating IGF-IR expression with poor outcomes in sarcoma patients [32]. This evidence concerns the gene IGF1 and osteosarcoma.